跳至主要内容
临床试验/NCT02285764
NCT02285764已完成不适用

NIGO Health- Nutritional Intervention During Gestation and Offspring Health

Abbott Nutrition6 个研究点 分布在 2 个国家目标入组 331 人开始时间: 2014年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
331
试验地点
6
主要终点
Maternal Oral Glucose Tolerance Test (OGTT)

研究概览

简要总结

The purpose of this study is to investigate the potential effects of a modified carbohydrate nutritional product for obese pregnant women to reduce maternal glycemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Voluntarily signed and dated an ICF, approved by an IEC/IRB and provided applicable privacy authorization prior to any participation in the study.
  • Obese (BMI ≥ 30) as determined by pre-pregnancy BMI.
  • ≥18 years of age.
  • ≥15+0 but ≤16+6 weeks gestation with a singleton pregnancy.
  • Willing to follow supplementation protocol and follow appropriate nutritional guidance and refrain from consuming other caloric nutritional supplements that are not approved by the study staff, if applicable.
  • Willing to provide body composition measures on infant at birth.
  • Willing to consider additional measures if follow-up studies are conducted.

排除标准

  • Adverse maternal and/or fetal medical history which is expected to alter blood glucose regulations.
  • Previously diagnosed diabetes, previous gestational diabetes, systemic lupus erythematodes, anti-phospholipid syndrome, known renal disease, treated hypertension, uncontrolled hypothyroidism and/or cancer.
  • Taking medications that can impact blood glucose.
  • Previous bariatric surgery.
  • Lactose intolerant and/or has milk protein allergy or requires a special diet regime.
  • Participating in another clinical trial that would impact participation in this study.

研究组 & 干预措施

Nutritional Supplement

Experimental

One 237 ml oral supplement consumed two times a day; Not commercially available.

干预措施: Nutritional Supplement (Other)

Standard of Care

Other

As determined by the study site

干预措施: Standard of Care (Other)

结局指标

主要结局

Maternal Oral Glucose Tolerance Test (OGTT)

时间窗: 27-28 weeks gestation

2 hour OGTT

次要结局

  • Maternal Fasting Blood Glucose(34-36 weeks gestation)
  • Neonatal Body Composition(Birth - 72 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验